Does Ozempic Cause Low Blood Sugar? What the Trials Actually Show

It's one of the first worries people have, and it makes sense. "Blood sugar medication" sounds like it should be able to push glucose too low. For GLP-1 drugs taken on their own, the trial evidence points the other way. Here's what the data says, and the one situation where the answer flips.

The short answer

Taken by itself, a GLP-1 receptor agonist rarely causes low blood sugar (hypoglycemia). The reason sits in how the drug works. It stimulates insulin release only when blood sugar is elevated, a property called glucose-dependent insulin secretion. As your glucose falls back toward normal, the drug's push on insulin eases off (Thomas 2023). It doesn't force insulin out regardless of your level the way some older drugs do, so it rarely overshoots into a low.

What the CGM trials found

This holds up in the data. The GRADE trial's CGM substudy compared four drugs added to metformin in people with type 2 diabetes. The GLP-1 (liraglutide) and the DPP-4 inhibitor (sitagliptin) produced the lowest glucose variability, the highest time in range, and the least time below range. They spent less time in hypoglycemia than insulin glargine and the sulfonylurea glimepiride (Bergenstal 2026). On the exact metric that captures "how often did blood sugar drop too low," the GLP-1 was among the safest options tested.

The one thing that changes the risk

Now the caveat that matters. A GLP-1 alone is low risk for hypoglycemia. Combined with insulin or a sulfonylurea (glipizide, glimepiride, glyburide), the picture changes. Those drugs push insulin regardless of your glucose level, and stacking them can drive blood sugar down too far. If you take one of them, your clinician may lower its dose when you start a GLP-1. That combination is the thing to watch, not the GLP-1 by itself.

If you're taking it for weight loss and don't have diabetes

The GRADE data comes from people with type 2 diabetes who weren't on insulin. If you're using a GLP-1 for weight and your glucose starts out normal, symptomatic lows are uncommon. Uncommon isn't the same as impossible, and this group hasn't been studied with CGM the way diabetes populations have. A sensor settles it honestly: instead of guessing, you can see whether your glucose ever actually dips low and how you feel when it does.

Low blood sugar symptoms worth knowing

Whatever you take, it helps to recognize a real low: shakiness, sweating, a racing heart, sudden hunger, irritability, trouble concentrating, lightheadedness. One sensor reading below 70 mg/dL isn't automatically an emergency, but a pattern of lows, or any low with symptoms, is worth raising with your clinician.

Used on its own, then, a GLP-1 is one of the lower-risk glucose drugs for causing hypoglycemia, because it only nudges insulin when your sugar is already high. The real risk lives in the insulin and sulfonylurea combinations. Know which camp you're in, and if you wear a CGM, let the sensor answer the question directly.